Telesis Bio develops and promotes the Gibson SOLA technology, a next-generation enzymatic synthesis platform.

Garuda Therapeutics develops proprietary hematopoietic stem cell therapies that are self-renewing, HLA-compatible, and transgene-free for immediate patient availability.

EnPlusOne Biosciences develops an enzyme-based platform for scalable RNA synthesis to advance RNA therapeutics and address manufacturing challenges.

Eleanor Health provides outpatient addiction treatment services using a whole-person care model focused on value-based payment structures and improved clinical outcomes.

Inflammatix develops molecular diagnostic tests, including the TriVerity™ Acute Infection and Sepsis Test, to improve the detection and treatment of sepsis in emergency departments.

Totus Medicines is a biotech company specializing in the discovery of novel small molecule drugs through the use of covalent libraries and artificial intelligence, focusing on diseases previously considered undruggable.

Aro Biotherapeutics is a clinical stage biotech company specializing in the development of tissue-targeted genetic medicines, including a potential treatment for Pompe Disease and new therapies for autoimmune disorders, using their proprietary Centyrin-siRNA platform.